Drug Company Speaker Fees Are Now Kickback Evidence: What the Eleventh Circuit's August 2026 Ruling Means for Florida Prescribers

If you took honoraria from a drug manufacturer to speak about one of its products, the Eleventh Circuit just told you what a federal jury can do with those payments. On August 18, 2026, the court affirmed the convictions and sentences of a Middle District of Florida pain physician and a pharmaceutical sales representative in a case built on a speaker program for a fentanyl-based drug. No diverted pills. No forged prescriptions. The government proved its case with speaker fees, attendance sheets, and prescription volume.

Poor attendance, honoraria that track prescribing volume, and events with no educational output are what convert lawful speaker compensation into criminal evidence under 42 U.S.C. 1320a-7b(b).

Key Takeaways

• The Eleventh Circuit affirmed Anti-Kickback convictions under 42 U.S.C. 1320a-7b(b) where the only payments at issue were drug company speaker honoraria.
• Sham educational programs, poor attendance, and honoraria that track prescribing volume are now settled proof of criminal intent in the Eleventh Circuit.
• Sales representatives face the same conspiracy exposure under 18 U.S.C. 371 as the prescribers they recruit, plus identity fraud counts.
• The court held any error in the sentencing loss calculation harmless because the district judge would have imposed the same sentence regardless.
• Florida sits inside the most active federal healthcare fraud enforcement corridor in the country, and the Middle and Southern Districts drive the caseload.

What the Eleventh Circuit Actually Decided

A federal grand jury in the Middle District of Florida indicted a pain medicine physician and a pharmaceutical sales representative over a manufacturer speaker program promoting a fentanyl-based product. The manufacturer paid physicians large honoraria for supposedly educational presentations. The physician collected substantial speaker payments. The sales representative arranged many of the events.

The trial evidence was not about medicine. It was about logistics. Events were poorly attended. Some drew people with no clinical reason to be there. Payments moved in step with prescription volume rather than educational output. The jury convicted the physician on conspiracy and Anti-Kickback counts, and the sales representative on conspiracy, Anti-Kickback violations, and identity fraud.

The Eleventh Circuit affirmed on every issue. The court held there was ample evidence of the physician's knowledge that the programs were shams and of the sales representative's knowing participation, found no abuse of discretion in how the district court answered the jury's questions, and held that any error in calculating the guideline range was harmless because the record showed the judge would have imposed the same sentences anyway.

What the Government Is Building These Cases On

Federal prosecutors stopped needing an insider to make a kickback case a long time ago. The evidence in a speaker program prosecution is almost entirely documentary, and the manufacturer already generated it. Sign-in sheets. Honoraria payment records. Sunshine Act disclosures. Internal sales targets. Prescriber-level prescription data bought from vendors. Put those data sets side by side and the correlation between payment and prescribing does the work a cooperating witness used to do.

Three data sets tell the story the government wants told. Who signed in. What the manufacturer paid. How the prescribing moved. The correlation between the second and the third is the case.

That is the same analytics posture driving federal healthcare fraud enforcement generally. The Justice Department's 2026 national takedown charged 455 defendants in schemes involving more than $6.5 billion in alleged fraud, and its healthcare fraud unit secured six trial convictions involving over $1.1 billion in losses across five districts in under three weeks, including a verdict in Fort Lauderdale. HHS-OIG runs a parallel exclusion track that continues after the criminal case ends.

By the time an agent knocks on your door, the government has usually already reconstructed years of your prescribing and payment history from records you never controlled.

Exposure: The Statutes and the Numbers

The Anti-Kickback Statute, 42 U.S.C. 1320a-7b(b), makes it a felony to knowingly and willfully solicit or receive remuneration for referring or arranging a good or service reimbursable by a federal healthcare program. Conviction carries up to ten years per count, fines, and mandatory exclusion from Medicare and Medicaid. Exclusion is often the sentence that ends a medical career.

Conspiracy under 18 U.S.C. 371 carries five years and sweeps in sales representatives, office managers, and marketing staff who never wrote a prescription. Health care fraud under 18 U.S.C. 1347 carries ten years, or twenty if serious bodily injury results. Where controlled substances are involved, prosecutors may add distribution counts under 21 U.S.C. 841. Aggravated identity theft under 18 U.S.C. 1028A adds a mandatory consecutive two years when patient identifiers paper an event or a claim.

Sentencing turns on loss. Under the fraud guideline, the loss figure drives most of the offense level, and prosecutors in kickback cases routinely argue that every prescription written during the payment period is tainted. That theory turns a few hundred thousand dollars in honoraria into a loss figure in the tens of millions. United States Sentencing Commission data is the starting point for arguing where a case should land.

There is a civil tail. The False Claims Act, 31 U.S.C. 3729, treats claims tainted by a kickback as false claims, and qui tam relators file these cases regularly.

Where the Sentence Actually Gets Decided

The harmless error holding deserves attention. The court did not say the loss calculation was right. It said the judge made a clear enough record that the sentence would have been identical either way. If the only place you fight loss is in written objections to the presentence report, an appellate court may never reach the question.

An alternative sentencing rationale on the record can insulate a sentence from appellate review of the loss figure entirely. The objection that preserves the issue is the one argued aloud at the hearing.

The argument that matters is made at the hearing, under 18 U.S.C. 3553(a), before the judge announces an alternative rationale. Loss methodology in a speaker program case is contestable on its own terms, because the government's theory that every prescription during the payment window is tainted assumes what it needs to prove. That fight belongs in open court, on a developed record, not in a footnote to a presentence report objection.

The Mistakes That Do the Real Damage

Talking to agents without counsel. Federal agents arrive with the payment records and prescription data already in hand. The interview is not information gathering. It is a chance to lock in a statement measurable against documents you have not seen. Every answer becomes a potential false statement count.

"By the time an agent knocks on your door, the government has usually already reconstructed years of your prescribing and payment history from records you never controlled."— Aaron M. Cohen, AMC Defense Law

Producing documents without a strategy. Calendars, event files, and email are usually the government's best evidence in a speaker program case, and a practice manager trying to be helpful often hands them over voluntarily. Nothing should leave the office without counsel reviewing it and a litigation hold in place.

Assuming a civil or administrative inquiry is the whole story. A payer audit or an HHS-OIG civil inquiry often runs alongside a grand jury investigation the target knows nothing about. Answers given in the civil track get used in the criminal one.

Waiting for the indictment. The most consequential period in a federal healthcare fraud case is the months before charges are filed, when charging decisions remain open. Pre-indictment defense representation is where these cases are shaped.

How These Cases Get Defended

Intent is the battlefield. The Anti-Kickback Statute requires knowing and willful conduct, and legitimate speaker programs exist. The defense case is built by separating genuine educational activity from the pattern the government points to, which means reconstructing attendance, content, and compensation methodology before the government's version calcifies.

Early intervention matters. A target letter response, a well-supported white paper, or a proffer on the right terms can narrow the counts under consideration or move a client from target to witness. That work happens before the grand jury votes.

If the case proceeds, sentencing positioning starts on day one, because loss methodology and the client's actual role need developing while records are intact. A federal healthcare fraud defense attorney who understands both the compliance framework around speaker programs and the guideline mechanics is doing two jobs at once from the first meeting.

Why the Timing Is Different Right Now

The Eleventh Circuit has now put its authority behind a documentary theory of kickback liability that needs no cooperating insider. Prosecutors in the Middle and Southern Districts of Florida read those opinions the week they issue, and a favorable circuit decision changes what a line prosecutor will charge.

If you speak for a manufacturer, run a practice where colleagues do, or sell for one, the window to get in front of a problem stays open only until the government decides it has enough. A federal criminal defense attorney brought in during the investigation stage can do things that become impossible after an indictment returns.

Common Questions

Facing a Federal Healthcare Fraud or Kickback Investigation in Florida?

AMC Defense Law represents physicians, practice owners, pharmacy operators, and pharmaceutical sales professionals in federal investigations involving the Anti-Kickback Statute, healthcare fraud, and controlled substance prescribing. If you have received a target letter, a grand jury subpoena, or a visit from federal agents, the conversation is worth having now rather than after an indictment. Consultations are confidential.

Reconstructing attendance, content, and compensation methodology before the government's version calcifies is the work that separates a lawful speaker program from the pattern prosecutors charge.

If you or your loved ones have been arrested or are under federal investigation involving a speaker program, prescribing, or healthcare fraud in Florida, call Aaron M. Cohen, 24 hours a day, to get help. Reach the firm for a confidential consultation.

This article is provided for general informational purposes only and does not constitute legal advice. Reading it does not create an attorney-client relationship. Every case turns on its own facts. If you are under investigation or facing charges, consult a qualified attorney about your situation.

About the author: Aaron M. Cohen is the founder of AMC Defense Law, a federal and state criminal defense firm based in Boca Raton, Florida. The firm represents clients in federal investigations and prosecutions involving healthcare fraud, white collar crime, peptide and compounded drug enforcement, and complex federal litigation, in Florida and nationwide.